Answers are grounded in this paper and cite their sources.
Multicenter analysis of laser treatment shows reduced infections and improved elasticity in cosmetic surgery patients, suggesting enhanced recovery.
Background Postoperative infections and suboptimal scar outcomes remain persistent challenges in cosmetic surgery, impairing patient satisfaction and quality of life. This study evaluates whether a standardized fractional ultra-pulse CO₂ laser regimen can mitigate these complications. Methods A multicenter retrospective cohort enrolled 562 adults undergoing elective rhinoplasty, liposuction, breast augmentation, facelift, abdominoplasty, or Botox. Laser eligibility (incision >3 cm, Fitzpatrick I–IV, no collagen-vascular disorder) was determined by an EMR-embedded checklist; 324 patients received a uniform three-stage laser protocol (pre-incision, immediate post-closure, day 10). All patients followed a five-day antibiotic regimen (oral cefalexin + topical mupirocin). Baseline covariates were balanced via IPTW. SSIs were microbiologically confirmed (aerobic, anaerobic, fungal, mycobacterial cultures with MALDI-TOF). Comparative analyses used Welch’s t -test and Fisher’s exact test; infection-free survival was assessed by Kaplan–Meier curves, and IPTW-adjusted Cox models quantified laser effects on SSI risk. Results Of 562 patients, 324 (58%) received laser therapy. Baseline demographics and comorbidities were balanced across groups (all p > 0.05). Laser-treated patients had faster healing (13.8 ± 5.7 vs. 17.0 ± 3.2 days; p < 0.001), lower CRP (11.3 ± 7.4 vs. 14.9 ± 4.4 mg/L; p < 0.001), thinner scars (2.44 ± 1.39 vs. 3.14 ± 0.78 mm; p < 0.001), and greater elasticity (0.85 ± 0.03 vs. 0.65 ± 0.03 AU; p < 0.001). Pigmentation, vascularity, and collagen III/I ratios were all significantly improved ( p < 0.001). SSIs were reduced (15% vs. 59%; p < 0.001), as were keloids (1.9% vs. 11%; p < 0.001). Satisfaction, quality-of-life scores, and return to activity favored the laser group (all p < 0.001). Kaplan–Meier curves confirmed superior 30-day infection-free survival (log-rank p < 0.001); IPTW-adjusted Cox regression showed a 72% reduced infection hazard (HR = 0.28; 95% CI: 0.19–0.41; p < 0.001). Conclusion Standardized fractional ultra-pulse CO₂ laser therapy reduces SSIs, improves scar outcomes, and enhances patient satisfaction in cosmetic surgery. These findings support wider adoption of laser protocols, warranting further prospective, pathogen-specific research.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: